
NanoTalks by Curapath is your gateway to the future of healthcare nanotechnology. In each episode, we explore the latest trends in lipid and polymer nanoparticles a groundbreaking field transforming how next-generation therapies and vaccines are developed. Discover how these tiny, multifunctional structures can enhance treatment effectiveness, minimize side effects, and open the door to innovations that once seemed out of reach. Join us as we delve into cutting-edge research, clinical insights, and the major advances shaping modern medicine
Hot topics
NanoTalks
- Miguel Ángel Esteve
- 30/07/2026
Selecting the right Polymer excipient for drug delivery
Understand the reasons that can impact polymer selection and why compatible its only a small part of the equation
This article explores how polymers can define drug perfomance. from stability and controlled release to manufacturability, scalability and compliance.You will see the key trade-offs between commonly used polymers and emerging material platforms.
Keep exploring Curapath Blog , there is more NanoTalks yet to explore
Recent Articles
- Filter by:
- All
- Polymers
- LNP
- Regulatory
- Analytics
- Miguel Ángel Esteve
- July 30, 2026
Historically polymer excipients have been described as inactive formulation components. In today's drug delivery...
- Miguel Ángel Esteve
- June 25, 2026
Polymers play a wide variety of rolesin today´s pharmaceutical landscape. They are used as excipients, drug delivery...
- Miguel Ángel Esteve
- May 26, 2026
In polymer–drug conjugates, the polymer is not only a passive carrier. Its chemistry, molecular weight, architecture,...
- Miguel Ángel Esteve
- April 28, 2026
Active targeting has emerged as one of the most promising strategies to unlock extrahepatic delivery of nanoparticles,...
- Miguel Ángel Esteve
- April 2, 2026
The outcome of this step directly defines critical quality attributes, including: Particle size Polydispersity index...
- Miguel Ángel Esteve
- February 26, 2026
Polymeric excipients play a critical role in modern therapeutic systems being a fundamental partin advanced and highly...
- Miguel Ángel Esteve
- January 29, 2026
Medical device–associated infections remain a major challenge across healthcare, especially for catheters, orthopedic...
- Miguel Ángel Esteve
- December 18, 2025
Polymer–drug conjugates (PDCs) represents a unique strategy in modern drug delivery: instead of encapsulating a drug...
- Miguel Ángel Esteve
- November 13, 2025
Lipid–polymer hybrid nanoparticles (LPHNs) are emerging as one of the most promising platforms in nanomedicine....
- Miguel Ángel Esteve
- October 15, 2025
Transfection, the process of introducing nucleic acids into cells, is a cornerstone of modern biotechnology, enabling...
- Miguel Ángel Esteve
- September 11, 2025
Functionalized polymers are revolutionizing pharmaceutical science by bridging chemistry and biology in ways that...
- Miguel Ángel Esteve
- July 30, 2025
Replacing PEG in lipid nanoparticles (LNPs) marks a critical evolution in the development of safer and more effective...
- Miguel Ángel Esteve
- July 2, 2025
Over the past 20 years, polymer-based drug delivery systems have evolved from experimental platforms to clinically...
- Miguel Ángel Esteve
- May 19, 2025
Messenger RNA (mRNA) technology surged into the global spotlight during the COVID-19 pandemic, showcasing its power to...
- Miguel Ángel Esteve
- April 29, 2025
Early-stage research frequently takes center stage in the fields of biopharmaceuticals and the development of advanced...
- Elena Gallon
- April 8, 2025
Sterile filtration and aseptic fill & finish are essential components in gene therapy manufacturing, critical for...
- Miguel Ángel Esteve
- March 20, 2025
Nanoparticle-based drug delivery has revolutionized how therapeutics can be transported and released within the human...
- Miguel Ángel Esteve
- March 11, 2025
Process Performance Qualification (PPQ) is a critical part of the pharmaceutical manufacturing validation lifecycle,...
- Miguel Ángel Esteve
- March 4, 2025
Currently, lipid nanoparticles (LNPs) stand as the predominant delivery system for emerging mRNA-based therapeutic...
- Miguel Ángel Esteve
- February 10, 2025
RNA‑based therapeutics have rapidly evolved from niche research tools to transformative medicines, powering...
- Miguel Ángel Esteve
- February 10, 2025
Peptide therapeutics offer high specificity and strong safety profiles, but their effectiveness depends on overcoming...
Keep updated
Sign Up for NanoTalks
Subscribe to NanoTalks, the magazine of Curapath. Stay up to date on the latest developments, trends and news in the world of non-viral vectors, plus discover the latest advances in nanobiotechnology.
